Yes, dogs can get toxic shock syndrome, though it is rare. Like the human version, canine toxic shock syndrome (TSS) is a serious, often fatal condition triggered by bacterial toxins that send the immune system into overdrive. It progresses rapidly, and most dogs are critically ill by the time they reach a veterinary hospital.
What Causes Toxic Shock in Dogs
TSS in dogs is not caused by the bacteria themselves doing direct damage. Instead, certain bacteria produce toxins that act as “superantigens,” essentially tricking the immune system into launching a massive, uncontrolled inflammatory response. This flood of inflammatory signals is what drives the dangerous symptoms: dangerously high fever, plummeting blood pressure, blood clotting problems, and eventually organ failure.
The bacteria most commonly responsible in dogs are Staphylococcus and Streptococcus species. On the staph side, both S. aureus and S. pseudintermedius (a species that commonly lives on dog skin) can produce the key superantigen toxins. S. aureus doesn’t typically colonize dog skin the way it does in humans, but when it does take hold, it can cause severe infections and, rarely, full toxic shock. Streptococcus canis is the strep species most often implicated in dogs, sometimes alongside a related species called S. equi subsp. zooepidemicus. In some documented cases, mixed infections involving more than one bacterial species have triggered the syndrome.
How It Differs From a Simple Infection
What separates TSS from a regular bacterial infection is the speed and scale of the body’s response. A typical skin infection stays relatively local. In TSS, the superantigen toxins bypass the normal, targeted immune response and activate a huge number of immune cells at once, flooding the bloodstream with inflammatory signals. This is what causes the condition to escalate from a localized problem to system-wide collapse, sometimes within hours.
Dogs don’t need to have a visible wound for TSS to develop. In a documented case involving necrotizing fasciitis (a deep, flesh-destroying infection), the dog had no history of skin disease or trauma at the infected site. This is not uncommon. The infection can start from something as minor as a small scratch, a surgical site, or even bacteria that were already living on the skin when the immune system was compromised.
Risk Factors
Any dog can theoretically develop TSS, but certain factors raise the risk. Dogs with weakened immune systems are more vulnerable. In one published case, a dog that developed necrotizing fasciitis and staph-related toxic shock had been receiving high doses of a steroid medication for an existing brain tumor and an insulin-producing tumor. The immunosuppressive effects of the steroid likely opened the door for bacteria that would normally be kept in check.
Other situations that may increase risk include recent surgery, open wounds, deep skin infections, and any condition or medication that suppresses the immune system. That said, TSS has occurred in dogs with no obvious predisposing factors, which is part of what makes it so difficult to predict.
Signs to Watch For
TSS moves fast, and the early signs can look deceptively like many other illnesses before rapidly worsening. In documented cases, dogs consistently presented with high fevers, typically between 40 and 41°C (104 to 106°F). Other hallmark signs include:
- Sudden, severe lethargy or collapse
- Respiratory distress: labored or rapid breathing, sometimes the primary visible symptom
- Pain that seems out of proportion: in dogs with necrotizing fasciitis, intense pain at a wound site that seems far worse than the injury would explain is a consistent finding
- Neurological changes: some dogs develop sudden weakness or partial paralysis in the limbs, or loss of bladder control
- Signs of poor circulation: pale gums, rapid heart rate, weakness
The lungs are frequently one of the first organs affected. In some cases, respiratory distress and shock were the primary reasons dogs were brought in. As the condition progresses, swelling and congestion can develop in the intestines, liver, kidneys, and brain.
How Veterinarians Diagnose It
Diagnosing TSS in dogs is challenging, partly because it’s so uncommon that it may not be the first thing a veterinarian suspects. There are no quick, definitive bedside tests for it. Diagnosis typically relies on a combination of clinical signs (high fever, low blood pressure, and at least one failing organ system) along with identification of the responsible bacteria from tissue samples or wound cultures.
Blood work in affected dogs shows a recognizable pattern. In a retrospective study of seven dogs with a cutaneous form of TSS, all seven had low albumin (a blood protein that drops during severe inflammation), all seven had low platelet counts (a sign of abnormal clotting), and all seven were anemic. Most had elevated liver enzymes, and more than half showed signs of kidney impairment. Interestingly, standard blood cultures came back negative in all five dogs that were tested, meaning the bacteria weren’t circulating freely in the blood. The damage was being done by the toxins, not by bacteria spreading through the bloodstream.
Some veterinarians are now looking at adapting the scoring criteria used to diagnose TSS in humans. In the same study, dogs that scored higher on the human TSS criteria had worse outcomes, suggesting these criteria could help veterinarians identify the condition earlier.
Treatment and Survival
TSS in dogs requires aggressive emergency care. Treatment centers on three priorities: killing the bacteria producing the toxins, supporting the organs that are failing, and managing the body’s runaway inflammatory response. Dogs typically receive antibiotics and intensive supportive care including fluids to maintain blood pressure.
When TSS is accompanied by necrotizing fasciitis, surgical removal of the infected, dying tissue is critical. In one study of dogs with streptococcal toxic shock, all four dogs that had necrotizing fasciitis and survived did so after surgical debridement combined with antibiotics and supportive care. By contrast, three dogs with streptococcal shock but without necrotizing fasciitis (meaning the infection was internal or diffuse rather than in a defined area that could be surgically cleaned) died or were euthanized within 48 hours of being admitted.
The overall mortality rate is high. In the retrospective study of seven dogs with cutaneous toxic shock syndrome, five of seven (roughly 70%) died or were euthanized. The two that survived received supportive care and antibiotics, but what distinguished them from the others was lower severity scores at the time of diagnosis. This underscores how much outcome depends on catching the condition early, before multiple organs have been compromised.
How It Compares to Human TSS
The basic mechanism is the same in dogs and humans: bacterial superantigens trigger an immune overreaction that damages the body’s own tissues. In humans, TSS became widely known through its association with tampon use in the 1980s, but in dogs, the triggers are different. Canine cases are most often linked to skin infections, wound infections, or necrotizing fasciitis rather than any retained foreign material.
The bacteria involved also differ slightly. While S. aureus is the classic culprit in human TSS, it’s not a normal resident of dog skin. Dogs are more commonly colonized by S. pseudintermedius, which can produce many of the same superantigen toxins. On the strep side, dogs are affected by S. canis rather than the Group A Streptococcus that causes streptococcal toxic shock in humans. Despite these species differences, the toxins these bacteria produce work in essentially the same way, and the resulting syndrome looks very similar across species.